KR870001984B1 - Process for preparing cephem derivatives - Google Patents

Process for preparing cephem derivatives Download PDF

Info

Publication number
KR870001984B1
KR870001984B1 KR1019850001654A KR850001654A KR870001984B1 KR 870001984 B1 KR870001984 B1 KR 870001984B1 KR 1019850001654 A KR1019850001654 A KR 1019850001654A KR 850001654 A KR850001654 A KR 850001654A KR 870001984 B1 KR870001984 B1 KR 870001984B1
Authority
KR
South Korea
Prior art keywords
formula
acid
reaction
syn
methoxyimino
Prior art date
Application number
KR1019850001654A
Other languages
Korean (ko)
Other versions
KR860007267A (en
Inventor
임성기
문순구
이관순
Original Assignee
한미약품공업 주식회사
임성기
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한미약품공업 주식회사, 임성기 filed Critical 한미약품공업 주식회사
Priority to KR1019850001654A priority Critical patent/KR870001984B1/en
Priority to IT67781/85A priority patent/IT1189604B/en
Priority to JP22109685A priority patent/JPS61186391A/en
Publication of KR860007267A publication Critical patent/KR860007267A/en
Application granted granted Critical
Publication of KR870001984B1 publication Critical patent/KR870001984B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Title compds. I [R1=H, metal salts; R2=H, acetoxymethyl, (1methyl-1H- tetrazol-5-yl) thiomethyl, etc. , useful as an antimicrobial agent, are prepd. Thus, a mixt. contg. 5.44g 7aminocephalosporanic acid, 100ml H2O, 40ml N,N-dimethyl-foramide, and 2.4g NaHCO3 is stirred for 10min, cooled to 10≰C, and treated with 7.87g 1-[α -syn-methoxyimino-α-(2-amino-thiazol-4-yl)acetyl -benzotriazol-3-oxide in 40ml N,N- dimethyl formamide. After 4h stirring, the reaction mixt. is reacted with 150ml ethylacetate twice to give 7.98g 7-[[2-2-(2-amino-thiazol-4- yl)-2-synmethoxyimino acetamido! cephalosporanic acid.

Description

세펨 유도체의 간단한 제조방법Simple Method of Making Cemfe Derivatives

본 발명은 항 미생물제로 유용한 다음구조식(Ⅰ)을 갖는 β-락탐 유도체의 새로운 제조방법에 관한 것이다.The present invention relates to a novel process for preparing β-lactam derivatives having the following structural formula (I) useful as an antimicrobial agent.

Figure kpo00001
Figure kpo00001

상기식에서,In the above formula,

R1은 수소 또는 금속염을 의미하여,R 1 means hydrogen or a metal salt,

R2는 수소, 아세톡시메틸, (1-메틸-1H-테트라졸-5-일) 티오메틸 또는(2,5-디하이드로-6-하이드록시-2-메틸-5-옥소-as-트리아진-3-일) 티오메틸을 의미한다.R 2 is hydrogen, acetoxymethyl, (1-methyl-1H-tetrazol-5-yl) thiomethyl or (2,5-dihydro-6-hydroxy-2-methyl-5-oxo-as-tri Azin-3-yl) thiomethyl.

본 발명은 세팔로스포란산 유도체의 신규의 진보된 제조방법에 관한 것으로서 광범위 균주(예로서, 스트렙톱코커스, 대장균, 푸로테우스, 시겔라, 살모넬라, 클렙시엘라, 세라타, 나이세리아속 등)에 대하여 강력한 항 미생물 효과를 나타내는 β-락탐 유도체를 제조하는 경제적인 방법을 제공한다.The present invention relates to a novel method for the preparation of cephalosporan acid derivatives, including a wide range of strains (eg Streptopococcus, Escherichia coli, Furoteus, Shigella, Salmonella, Klebsiella, Serata, Neisseria, etc.). An economical method for producing β-lactam derivatives exhibiting strong anti-microbial effects against) is provided.

반합성 β-락탐 항생제의 제조를 위한 여러가지 방법이 문헌이나 특허에 발표되어 있으며, 7-아미노데옥시세팔로스포란산(7-ADCA), 그리고 7-아미노세팔로스포란산(7-ACA)의 유도체를 유기산의 반응성 유도체와 축합시켜 펩타이드 결합을 이루어 다양한 β-락탐 항생제들을 제조하여 왔다.Various methods for the preparation of semi-synthetic β-lactam antibiotics have been published in the literature and patents, and include 7-aminodeoxycephalosporranic acid (7-ADCA) and 7-aminocephalosporranic acid (7-ACA). The derivatives have been condensed with reactive derivatives of organic acids to form peptide bonds to produce various β-lactam antibiotics.

구조식(Ⅰ)의 아실화물을 제조하기 위한 기존 방법들을 살펴보면 구조식(Ⅱ)에 R기를 도입하여 아민기를 보호한다음에 유기산을 반응성 유도체로 전환하여 아실화 반응을 시켜왔는데, 이러한 반응성 유도체로는 산 염화물, 반응성 에스테르 및 반응성 아마이드 등이 있다.Existing methods for preparing acylates of structural formula (I) have been introduced into the structural formula (II) to protect the amine groups, and then convert organic acids to reactive derivatives to carry out acylation reactions. Reactive esters and reactive amides.

Figure kpo00002
Figure kpo00002

유기산(Ⅱ)의 산염화물을 제조하기 위한 방법으로는 일본 특허공개 제77-102293, 78-68796, 78-34795, 79-52096, 79-157596 및 영국특허 2025933등에 보고되어 있으며, 이들 방법에 의하면 유기산(Ⅱ)를 티오닐클로라이드(SOCl2), 포스포러스펜타클로라이드(PCl5) 및 포스포러스옥시클로라이드(POCl3)등을 사용하여 유기산(Ⅱ)의 산염화물을 제조한 후, 7-ADCA와 또는 7-ACA와 아실화 반응을 시킨 후 보호기 R을 제거하여 구조식(Ⅰ)의 화합물을 제조하였다. 그러나 이 방법들은 반응조건이 까다롭고, 아미노 보호공정 및 아미노 보호기 제거공정이 더 필요할 뿐만 아니라, 산염화물이 안정하지 못한 결점을 갖고 있다.Methods for preparing acid chlorides of organic acids (II) are reported in Japanese Patent Application Laid-Open Nos. 77-102293, 78-68796, 78-34795, 79-52096, 79-157596 and British Patent 2025933. (II) was prepared using the thionyl chloride (SOCl 2 ), phosphorus pentachloride (PCl 5 ), phosphorus oxychloride (POCl 3 ) and the like to prepare an acid chloride of organic acid (II), and then using 7-ADCA or 7 After the acylation reaction with -ACA, the protecting group R was removed to prepare a compound of formula (I). However, these methods are difficult to react, require more amino protecting step and amino protecting group removal process, and have the disadvantage that the acid chloride is not stable.

유기산(Ⅱ)의 반응성 에스테르를 제조하여 아실화 반응을 시켜 구조식(Ⅰ)의 화합물을 제조하는 방법으로는 일본 특허공개 제79-95593, 77-102293, 81-152488호 등에 보고되어 있으며, 이들 방법에 의하면 구조식(Ⅱ) 반응성 유도체로 구조식(Ⅱ) 화합물의 2-피리딘 치오에스테르, 2-벤조 치아졸 에스테르, 1-하이드록시벤조트리아졸 에스테르를 제조하여 아실화 반응을 시켜 구조식(Ⅰ) 화합물을 제조하였으나, 에스테르 제조시에 부반응을 동반하고 수율이 낮은 결점이 있고, 아실화 반응을 시킬때 장시간을 요하고 있다. 또한 산아마이드 및 혼합산 무수물에 의한 방법도 있으나, 상기 방법과 마찬가지의 문제점을 갖고 있다. 이와같은 기존의 반응성 유도체를 사용하여 아실화 반응을 시킬때는 먼저 구조식(Ⅱ) 화합물의 아민기를 R로 보호하고 산염화물, 반응성 에스테르등의 반응성 유도체를 제조한 후 아실화 반응을 시키고 나서 다시 보호기능기를 제거해야 하는 번거로움이 있다.As a method for preparing a compound of structural formula (I) by preparing a reactive ester of an organic acid (II) to undergo an acylation reaction, it has been reported in Japanese Patent Application Laid-Open Nos. 79-95593, 77-102293, 81-152488, and the like. According to the formula (II), 2-pyridine thiester, 2-benzo thiazole ester, and 1-hydroxybenzotriazole ester of the compound of formula (II) were prepared as a reactive derivative to undergo acylation reaction. Although it has been prepared, there are drawbacks with side reactions and low yields in the preparation of esters, and it takes a long time for the acylation reactions. There is also a method using acid amide and mixed acid anhydride, but has the same problem as the above method. When the acylation reaction is carried out using such a conventional reactive derivative, the amine group of the structural formula (II) compound is first protected by R, and a reactive derivative such as an acid chloride or a reactive ester is prepared. There is a hassle to remove.

본 발명에서는 구조식(Ⅱ) 화합물의 아민기를 보호하지 않고 곧바로 신규의 반응성 아마이드의 용매화물만을 선택적으로 제조하여 간편하게 높은 수율로 아실화 반응을 시키는 방법을 제공한다. 1-하이드록시벤조트리아졸 에스테르와 그 아미이드를 이용하는 방법은 일본 특허공개 제79-95593에 보고되어 있는데 이 방법으로는 구조식(Ⅶ)의 반응성 에스테르와 구조식(Ⅷ)의 화합물이 거의 같은 비율로 생성되며, 구조식(Ⅶ)의 반응성 에스테르는 대단히 불안정하여 구조식(Ⅱ)의 산과 구조식(Ⅴ) 의 알콜로 쉽게 분해되기 때문에, 분리하여 아실화 반응을 시키는데 어려움이 있다.The present invention provides a method of selectively preparing only a solvate of a new reactive amide immediately without protecting the amine group of the compound of formula (II), and simply providing an acylation reaction in a high yield. A method of using 1-hydroxybenzotriazole ester and its amide is reported in Japanese Patent Laid-Open No. 79-95593, in which the reactive ester of the structural formula and the compound of the structural formula Generated and the reactive ester of formula (V) is very unstable and readily decomposes into the acid of formula (II) and the alcohol of formula (V), which makes it difficult to separate and acylate.

Figure kpo00003
Figure kpo00003

본 발명자들은 오랜 연구를 행한 결과, 구조식(Ⅳ)의 디알킬(또는 디아릴) 클로로치오포스페이트와 구조식(Ⅴ)의 1-하이드록시벤조트리아졸을 반응시켜 구조식(Ⅵ)의 화합물을 만들고 여기에 구조식(Ⅱ)의 유기산을 반응시키면 구조식(Ⅷ)의 반응성 아마이드만을 용매화물의 형태로 선택적으로 높은 수율로 얻을 수 있으며, 이 반응성 아마이드의 용매화물을 구조식(Ⅲ) 화합물과 상온에서 반응시켜 목적하는 아실화물(Ⅰ)을 높은 수율로 제조하여, 간편하게 분리하는 방법을 발견하여 본 발명을 완성하게 되었다.The present inventors have conducted a long study, and reacted the dialkyl (or diaryl) chlorothio phosphate of formula (IV) with 1-hydroxybenzotriazole of formula (V) to make a compound of formula (VI) By reacting the organic acid of formula (II), only the reactive amide of formula (V) can be selectively obtained in high yield in the form of a solvate, and the solvate of the reactive amide is reacted with the compound of formula (III) at room temperature. The present invention has been accomplished by finding a method for preparing acylate (I) in high yield and for easy separation.

따라서, 본 발명의 목적은 구조식(Ⅳ)의 디알킬(디아릴) 클로로치오포스페이트와 구조식(Ⅴ)의 1-하이드록시벤조트리아졸의 반응에서 생기는 구조식(Ⅵ)의 화합물에 구조식(Ⅱ)의 유기산을 반응시켜 신규의 반응성 아마이드인 구조식(Ⅷ) 화합물의 용매화물을 제조하고, 이 용매화물을 구조식(Ⅲ) 화합물과 반응시켜 구조식(Ⅰ) 화합물을 높은 수율고 제조하는 새로운 아실화 방법을 제공하는 것이다.Accordingly, it is an object of the present invention to provide compounds of formula (VI) resulting from the reaction of dialkyl (diaryl) chlorothiophosphate of formula (IV) with 1-hydroxybenzotriazole of formula (V). A new acylation method is prepared by reacting an organic acid to prepare a solvate of a compound of formula (IV), which is a novel reactive amide, and reacting the solvate with a compound of formula (III) to produce a compound of formula (I) in high yield. It is.

본 명세서에서 R4로 표시되는 알킬기의 예는 에틸이고, 아릴기의 예는 페닐이다.Examples of the alkyl group represented by R 4 in this specification are ethyl, and an example of an aryl group is phenyl.

본 발명의 방법을 반응식으로 표시하면 다음과 같다.The process of the present invention is represented by the following scheme.

Figure kpo00004
Figure kpo00004

상기식에서 R1,R2,R4는 전술한 바와 같다.Wherein R 1 , R 2 , R 4 are as described above.

이들 반응중에서 구조식(Ⅵ)의 디알킬(또는 디아릴) 1-하이드록시벤조트리아졸릴치오포스페이트를 제조하기 위한 용매로는 테트라하이드로푸란, N,N-디메틸포름아마이드, N,N-디메틸아세트아마이드등을 사용함이 바람직하며, 이 중 테트라하이드로푸란이 가장 적합하다. 사용되는 염기로는 트리에틸아민, 트리메틸아민, 피리딘등이 있으나, 이중 트리에틸아민이 가장 적합하다. 신규의 구조식(Ⅵ)의 디알킬(또는 디아릴) 1-하이드록시벤조트리아졸릴치오포스페이트는 불안정하기 때문에 용액중에서 분리하지 않고 구조식(Ⅱ)의 유기산의 용액과 반응시키게 되는데, 이때 유기산을 녹이는 용매로는 N,N-디메틸포름아마이드, N,N-디메틸아세트아마이드가 적합하다. 사용되는 염기로는 트리에틸아민, 트리메틸아민, 피리딘등이 있으나, 이중 트리에틸아민이 가장 적합하다. 반응은 통상 실온에서 진행되며, 1-2시간이면 반응성 아마이드의 용매화물이 침전으로 얻어진다.Among these reactions, solvents for preparing the dialkyl (or diaryl) 1-hydroxybenzotriazolylthiophosphate of formula (VI) include tetrahydrofuran, N, N-dimethylformamide, N, N-dimethylacetamide And the like are preferred, of which tetrahydrofuran is most suitable. Bases used include triethylamine, trimethylamine, pyridine and the like, of which triethylamine is most suitable. The new dialkyl (or diaryl) 1-hydroxybenzotriazolylthiophosphate of formula (VI) is unstable and is reacted with a solution of the organic acid of formula (II) without separation in solution, where a solvent is used to dissolve the organic acid. Suitable examples are N, N-dimethylformamide and N, N-dimethylacetamide. Bases used include triethylamine, trimethylamine, pyridine and the like, of which triethylamine is most suitable. The reaction usually proceeds at room temperature and within 1-2 hours solvates of the reactive amides are obtained by precipitation.

다음으로, 화합물(Ⅰ)을 제조하는 아실화 반응은 염기성 수용액과 유기용매의 혼합용액에서 수행하고, 사용되는 염기로는 탄산수소나트륨, 탄산수소칼륨, 트리에틸아민, 탄산나트륨, 탄산칼륨 등이 있으며, 이중 탄산수소나트륨을 사용하는 것이 바람직하다. 유기용매로는 아세토니트릴, 아세톤, 에틸아세테이드, 테트라 하이드로푸란, N,N-디메틸포름아마이드, N,N-디메틸아세트아마이드, 디옥산 등을 사용하며, 이 중 아세토니트릴, 아세톤, 테트라하이드로푸란, N,N-디메틸포름아마이드가 적당하다. 반응수행방법은 구조식(Ⅲ) 화합물을 상기 염기성 수용액에 용해시키고 유기용매를 가한후, 반응성 아마이드(Ⅷ)용매화물을 결정상태로 가하여 상온에서 1-5시간 교반하면 정량적으로 반응이 진행된다.Next, the acylation reaction for preparing compound (I) is carried out in a mixed solution of a basic aqueous solution and an organic solvent, and bases used include sodium bicarbonate, potassium bicarbonate, triethylamine, sodium carbonate, potassium carbonate, and the like. It is preferable to use double sodium bicarbonate. As the organic solvent, acetonitrile, acetone, ethyl acetate, tetra hydrofuran, N, N-dimethylformamide, N, N-dimethylacetamide, dioxane, etc. are used, among which acetonitrile, acetone, tetrahydro Furan and N, N-dimethylformamide are suitable. In the reaction performance method, the structural formula (III) compound is dissolved in the basic aqueous solution, an organic solvent is added thereto, and then a reactive amide solvate is added to a crystalline state and stirred at room temperature for 1-5 hours to proceed quantitatively.

다음에 유기용매를 감압 증류하여 제거하고, 물층의 pH를 4.0으로 맞추어 부생하는 1-하이드록시벤조트리아졸을 제거하고, 물층을 소금으로 포화시킨 후, 에틸아세테이트를 가하여 교반하면서 pH를 등전점으로 조절하면 구조식(Ⅰ)의 화합물이 침전으로 얻어진다. 이 반응에서 물과 유기용매의 사용량은 구조식(Ⅲ)화합물에 대하여 10-30배가 적당하며 물과 유기용매의 비율은 2 : 1 내지 1 : 2로 한다.Next, the organic solvent was distilled off under reduced pressure, the by-product 1-hydroxybenzotriazole was removed by adjusting the pH of the water layer to 4.0, the water layer was saturated with salt, and then the pH was adjusted to an isoelectric point by adding ethyl acetate and stirring. The lower surface of the compound of formula (I) is obtained by precipitation. The amount of water and organic solvent used in this reaction is 10 to 30 times as appropriate for the compound of formula (III), and the ratio of water and organic solvent is 2: 1 to 1: 2.

본 발명은 기존의 아실화 방법과 비교할 때 다음과 같은 장점이 있다.The present invention has the following advantages compared to the conventional acylation method.

1. 값이 저렴하고 쉽게 구할 수 있는 디알킬(또는 디아릴) 클로로치오포스페이트와 1-하이드록시벤조트리아졸의 반응에 의해 생기는 신규의 구조식(Ⅵ)의 디알킬(또는 디아릴) 1-하이드록시벤조트리아졸릴치오포스페이트를 사용하여 반응성 아마이드(Ⅷ)의 용매화물을 높은 수율로 제조하며,1. A novel, low-cost, readily available dialkyl (or diaryl) dialkyl (or diaryl) 1-hydride of the formula (VI) produced by the reaction of 1-hydroxybenzotriazole with dialkyl (or diaryl) chlorothiophosphate. The solvate of the reactive amide is prepared in high yield using oxybenzotriazolylthiophosphate,

2. 이 반응성 아마이드(Ⅷ)의 용매화물은 여러 유기용매에 대하여 용해가 극히 잘 되기 때문에, 아실화반응이 균일하게 진행되어 단시간에 반응이 완료되고,2. Since the solvate of this reactive amide is extremely soluble in various organic solvents, the acylation reaction proceeds uniformly and the reaction is completed in a short time.

3. 산염화물이나 혼합산 무수물과는 달리 반응성 아마이드(Ⅷ)의 용매화물은 상온에서 대단히 안정하므로 상품화할 수 있고,3. Unlike acid chlorides or mixed acid anhydrides, solvates of reactive amides are very stable at room temperature and can be commercialized.

4. 반응을 실온에서 행할 수 있는 이점이 있고,4. There is an advantage that the reaction can be carried out at room temperature,

5. 아미노기를 보호하지 않고도 부반응없이 반응이 거의 정량적으로 진행되기 때문에, 아미노산의 아민기를 보호한 후 다시 보호기를 제거해야 하는 불편이 없고,5. Since the reaction proceeds almost quantitatively without side reactions without protecting the amino group, there is no inconvenience of protecting the amine group of the amino acid and then removing the protecting group again.

6. 반응이 완료되면 수용액중에서 간단히 목적화합물을 분래해낼 수 있으므로,6. When the reaction is completed, the target compound can be easily separated in aqueous solution.

기존의 방법보다 제조시설을 간단히 할 수 있고 까다로운 공정이 없으므로, 경제적이고도 새로운 아실화 방법을 제공한다.The manufacturing facility is simpler than the existing method and there is no complicated process, thus providing an economical and new method of acylation.

다음의 실시예는 본 발명의 방법을 좀 더 상세히 설명하는 것이며, 이들 실시예가 본 발명을 제한하는 것은 아니다.The following examples illustrate the method of the invention in more detail, and these examples do not limit the invention.

[실시예 1]Example 1

1-하이드록시벤조트리아졸 13.5g(0.1M)을 테트라하이드로푸란 80ml와 트리에틸아민 16.8ml(0.12M)에 완전히 용해시키고 여기에 디에틸클로로치오포스페이트 20.8g(0.11M)을 가한다. 반응이 진행되면서 트리에틸아민 염산염이 결정으로 석출된다. 반응용액을 실온에서 1시간 교반후 생긴 침전을 여과하고 테트라하이드로푸란 20ml로 세척한다. 2-(2-아미노치아졸-4-일)-2-syn-메톡시이미노초산 20.1g (0.1M)을 N,N-디메틸포름아마이드 100ml와 트리에틸아민 13.9mg(0.1M)에 녹인 용액을 앞에서 제조한 테트라하이드로푸란 용액에 10분간에 걸쳐 적가한다.13.5 g (0.1 M) of 1-hydroxybenzotriazole is completely dissolved in 80 ml of tetrahydrofuran and 16.8 ml (0.12 M) of triethylamine, and 20.8 g (0.11 M) of diethylchlorothiophosphate is added thereto. As the reaction proceeds, triethylamine hydrochloride precipitates as crystals. The reaction solution was stirred at room temperature for 1 hour, and the precipitate formed was filtered and washed with 20 ml of tetrahydrofuran. 20.1 g (0.1 M) of 2- (2-aminothiazol-4-yl) -2-syn-methoxyiminoacetic acid in 100 ml of N, N-dimethylformamide and 13.9 mg (0.1 M) of triethylamine Was added dropwise to the tetrahydrofuran solution prepared above for 10 minutes.

위의 반응 용액을 상온에서 1시간 교반하면 결정이 생성되기 시작한다. 상온에서 1시간 더 교반해주고 0-5℃에서 2시간 교반해 주고 여과하면, 반응성 아마이드인 1-[α-syn-메톡시이미노-α-(2-아미노치아졸-4-일)아세틸]-벤조트리아졸-3-옥사이드의 DMF 용매화물을 얻는다.After stirring the reaction solution at room temperature for 1 hour, crystals start to form. After stirring for 1 hour at room temperature and stirring for 2 hours at 0-5 ° C, and filtered, the reactive amide 1- [α-syn-methoxyimino-α- (2-aminothiazol-4-yl) acetyl]- Obtain a DMF solvate of benzotriazole-3-oxide.

수율 : 36.0g(92%)Yield: 36.0 g (92%)

IR(KBr, ㎝-1) : 1730IR (KBr, cm -1 ): 1730

NMR(DMSO-d6,δ, ppm) : 2.27(3H,s,-N-CH3), 2.90(3H,s,-N-CH3),NMR (DMSO-d 6 , δ, ppm): 2.27 (3H, s, -N-CH 3 ), 2.90 (3H, s, -N-CH 3 ),

3.90(3H,s,-OCH3), 7.07(1H,s, 치아졸-H), 7.13(2H,s,-NH2), 7.5-8.5(4H,m, 벤조트리아졸-H), 7.97(1H, s,

Figure kpo00005
3.90 (3H, s, -OCH 3 ), 7.07 (1H, s, chiazole-H), 7.13 (2H, s, -NH 2 ), 7.5-8.5 (4H, m, benzotriazole-H), 7.97 (1H, s,
Figure kpo00005

mp (℃) : 156-159(분해)mp (° C): 156-159 (decomposition)

[실시예 2]Example 2

테트라하이드로푸란 대신에 용매로 N,N-디메틸포름아마이드(DMF)를 동량 사용하여 실시예 1 의 방법과 유사한 방법으로 반응을 행하여 반응성 아마이드인 1-[α-syn-메톡시이미노-α-(2-아미노치아졸-4-일)-아세틸]-벤조트리아졸-3-옥사이드의 DMF 용매화물을 얻는다.Instead of tetrahydrofuran, the reaction was carried out in the same manner as in Example 1 using N, N-dimethylformamide (DMF) as a solvent, and the reactive amide 1- [α-syn-methoxyimino-α- ( DMF solvate of 2-aminothiazol-4-yl) -acetyl] -benzotriazole-3-oxide is obtained.

수율 : 34.4g(88%)Yield: 34.4 g (88%)

IR 및 NMR 데이타는 실시예 1 과 동일함.IR and NMR data are the same as in Example 1.

[실시예 3]Example 3

디에틸클로로치오포스페이트 대신에 디페닐클로로치오포스페이트 31.3g (0.11M)을 사용하여 실시예 1 의 방법과 유사한 방법으로 반응을 행하여 1-[α-syn-메톡시이미노-α-(2-아미노치아졸-4-일)-아세틸]-벤조트리아졸-3-옥사이드의 DMF용매화물을 얻는다.The reaction was carried out in a manner similar to that of Example 1, using 31.3 g (0.11 M) of diphenylchlorothiophosphate instead of diethylchlorothiophosphate to give 1- [α-syn-methoxyimino-α- (2-amino Obtain a DMF solvate of chiazol-4-yl) -acetyl] -benzotriazole-3-oxide.

수율 : 36.4g(93%)Yield: 36.4 g (93%)

IR 및 NMR 데이타는 실시예 1 과 동일함.IR and NMR data are the same as in Example 1.

[실시예 4]Example 4

테트라하이드로푸란과 N,N-디메틸포름아마이드 대신에 N,N-디메틸아세트아마이드를 동량 사용하여 실시예 1 의 방법과 유사한 방법으로 반응을 행하여 1-[α-syn-메톡시이미노-α-(2-아미노치아졸-4-일)-아세틸]-벤조트리아졸-3-옥사이드의 DMA용매화물을 얻는다.Instead of tetrahydrofuran and N, N-dimethylformamide, the reaction was carried out in the same manner as in Example 1 using N, N-dimethylacetamide in the same amount, and 1- [α-syn-methoxyimino-α- ( A DMA solvate of 2-aminothiazol-4-yl) -acetyl] -benzotriazole-3-oxide is obtained.

수율 : 34.4g(85%)Yield: 34.4 g (85%)

IR(KBr, ㎝-1) : 1730(아마이드카보닐), 1655(DMA 카보닐)IR (KBr, cm -1 ): 1730 (amide carbonyl), 1655 (DMA carbonyl)

NMR(DMSO-d6δ, ppm) :

Figure kpo00006
, 2.30(3H,s,-N-CH3), 2.95(3H,s,-N-CH3), 3.95(3H,s,-OCH3), 7.10(1H, 치아졸-H), 7.20(2H,s,-NH2), 7.4-8.4(4H, m, 벤조트리아졸-H)NMR (DMSO-d 6 δ, ppm):
Figure kpo00006
, 2.30 (3H, s, -N-CH 3 ), 2.95 (3H, s, -N-CH 3 ), 3.95 (3H, s, -OCH 3 ), 7.10 (1H, chiazole-H), 7.20 ( 2H, s, -NH 2 ), 7.4-8.4 (4H, m, benzotriazole-H)

mp(℃) : 157-160(분해)mp (℃): 157-160 (decomposition)

[실시예 5]Example 5

7-아미노세팔로스포란산 5.4g을 물 100ml와 아세토니트릴 200ml에 혼탁하고 탄산수소나트륨 2.4g을 가하여 실온에서 10분간 교반하여 완전히 용해시킨다.5.4 g of 7-aminocephalosporranic acid was turbid in 100 ml of water and 200 ml of acetonitrile, 2.4 g of sodium bicarbonate was added thereto, and stirred at room temperature for 10 minutes to dissolve completely.

여기에 실시예 1 에서 제조한 1-[α-syn-메톡시이미노-α-(2-아미노치아졸-4-일)-아세틸]-벤조트리아졸-3-옥사이드의 DMF용매화물 6.40g을 가하고 상온에서 4 시간 교반하면 반응이 완결된다. 용액중의 아세토니트릴을 감압 증류하여 제거하고, 0-5℃로 냉각하면서 2N-염산으로 pH 4.0으로 조절하여 1시간 교반한 다음 결정을 여과하여 제거한다. 여액을 소금으로 포화시키고 에틸아세테이트 120ml를 가하여 강하게 교반하면서 2N-염산으로 pH 2.5로 조절하면 황백색 침전이 생성된다. 1 시간 교반후 여과하여 건조하면 목적하는 7-[[2-(2-아미노치아졸-4-일)-2-syn-메톡시 이미노] 아세트아미도] 세팔로스포란산(cefotaxime)을 얻는다.6.40 g of a DMF solvate of 1- [α-syn-methoxyimino-α- (2-aminothiazol-4-yl) -acetyl] -benzotriazole-3-oxide prepared in Example 1 was added thereto. After the addition and stirring at room temperature for 4 hours, the reaction is completed. The acetonitrile in the solution was distilled off under reduced pressure, the mixture was adjusted to pH 4.0 with 2N hydrochloric acid while cooling to 0-5 ° C, stirred for 1 hour, and the crystals were filtered off. Saturate the filtrate with salt, add 120 ml of ethyl acetate and adjust to pH 2.5 with 2N hydrochloric acid under vigorous stirring to produce an off-white precipitate. After stirring for 1 hour, the mixture was filtered and dried to give the desired 7-[[2- (2-aminothiazol-4-yl) -2-syn-methoxy imino] acetamido] cephataxanoic acid (cefotaxime). Get

수율 : 8.65g(95%)Yield: 8.65 g (95%)

IR (KBr, ㎝-1) : 1780(β-락탐카르보닐)IR (KBr, cm- 1 ): 1780 (β-lactamcarbonyl)

NMR(D2O/NaHCO3,δ, ppm) :

Figure kpo00007
, 3.53(2H,d,C2-H), 4.02 (3H,s, -OCH3), 4.84(2H,d,3-CH2-), 5.20(1H,d,C6-H), 5.82(1H,d,C7-H), 6.97(1H,s, 치아졸-H).NMR (D 2 O / NaHCO 3 , δ, ppm):
Figure kpo00007
, 3.53 (2H, d, C 2 -H), 4.02 (3H, s, -OCH 3 ), 4.84 (2H, d, 3-CH 2- ), 5.20 (1H, d, C 6 -H), 5.82 (1H, d, C 7 -H), 6.97 (1H, s, chiazole-H).

[실시예 6]Example 6

아세토니트릴 대신에 테트라하이드로푸란을 동량 사용하여 실시예 5의 방법으로 반응시켜 목적하는 7-[[2-(2-아미노치아졸-4-일)-2-syn-메톡시이미노] 아세트아미도] 세팔로스포란산을 얻는다.Tetrahydrofuran was used in place of acetonitrile and reacted in the same manner as in Example 5 to obtain the desired 7-[[2- (2-aminothiazol-4-yl) -2-syn-methoxyimino] acetamido. Get cephalosporan acid.

수율 : 8.44g(93%)Yield: 8.44 g (93%)

IR 및 NMR은 실시예 5 와 동일함.IR and NMR are the same as in Example 5.

[실시예 7]Example 7

아세토니트릴 대신에 아세톤을 동량 사용하여 실시예 5의 방법으로 반응시켜 목적하는 7-[[2-(2-아미노치아졸-4-일)-2-syn-메톡시이미노] 아세트아미도] 세팔로스포란산을 얻는다.Using the same amount of acetone instead of acetonitrile, the reaction was carried out by the method of Example 5 to obtain the desired 7-[[2- (2-aminothiazol-4-yl) -2-syn-methoxyimino] acetamido] Obtains palosporranic acid.

수율 : 8.26g(91%)Yield: 8.26 g (91%)

IR, NMR은 실시예 5 와 동일함.IR, NMR are the same as in Example 5.

[실시예 8]Example 8

7-아미노세팔로스포란산 5.44g을 물 100ml와 N,N-디메틸포름아마이드 40ml에 혼탁시키고 탄산수소나트륨 2.4g을 가하여 실온에서 10분간 교반하여 용해시킨 후 10℃ 이하로 냉각시킨다. 여기에 1-[α-syn-메톡시이미노-α-(2-아미노티아졸-4-일)아세틸]-벤조트리아졸-3-옥사이드의 DMF용매화물 7.87g을 N,N-디메틸포름아마이드 40ml에 용해시킨 용액을 10분간에 걸쳐 적가한다.5.44 g of 7-aminocephalosporranic acid was turbid in 100 ml of water and 40 ml of N, N-dimethylformamide, 2.4 g of sodium bicarbonate was added thereto, stirred at room temperature for 10 minutes, dissolved, and cooled to 10 ° C or lower. 7.87 g of DMF solvate of 1- [α-syn-methoxyimino-α- (2-aminothiazol-4-yl) acetyl] -benzotriazole-3-oxide was added to N, N-dimethylformamide. The solution dissolved in 40 ml was added dropwise over 10 minutes.

위의 용액을 상온에서 4시간 교반하면 반응이 완결된다. 에틸아세테이트 150ml로 2회에 걸쳐 반응 용액중의 N,N-디메틸포름아마이드를 추출하여 제거하고, 물층을 염화나트륨으로 포화시킨다. 5℃로 용액을 냉각시키고 2N-HCl로 pH 4.0으로 조절후 1시간 교반하고 불용물을 여과하여 제거한 후 여액을 다시 pH 2.5로 조절하면 황백색의 침전을 얻는다. 1시간 교반하여 준 후 여과하고 소량의 물로 세척하여 건조하면 7-[[2-(2-아미노티아졸-4-일)-2-syn-메톡시이미노] 아세트아미도] 세팔로스포란산을 얻는다.When the above solution is stirred at room temperature for 4 hours, the reaction is completed. 150 ml of ethyl acetate was extracted twice with N, N-dimethylformamide in the reaction solution, and the water layer was saturated with sodium chloride. The solution was cooled to 5 ° C., adjusted to pH 4.0 with 2N-HCl, stirred for 1 hour, the insolubles were filtered off, and the filtrate was adjusted to pH 2.5 again to obtain an off-white precipitate. After stirring for 1 hour, filtered, washed with a small amount of water and dried to obtain 7-[[2- (2-aminothiazol-4-yl) -2-syn-methoxyimino] acetamido] cephalosporonic acid Get

수율 : 7.98g(88%)Yield: 7.98 g (88%)

IR, NMR은 실시예 5 와 동일함.IR, NMR are the same as in Example 5.

[실시예 9]Example 9

N,N-디메틸포름아마이드 대신에 N,N-디메틸아세트아마이드를 동량 사용하여 실시예 8의 방법으로 반응시켜서 목적하는 7-[[2-2-아미노치아졸-4-일)-2-syn-메톡시이미노] 아세트아미도] 세팔로스포란산을 얻는다.Instead of N, N-dimethylformamide, the same amount of N, N-dimethylacetamide was used as the reaction of Example 8 to react with the desired 7-[[2-2-aminothiazol-4-yl) -2-syn -Methoxyimino] acetamido] cephalosporan acid is obtained.

수율 : 7.96g(88%)Yield: 7.96 g (88%)

IR, NMR은 실시예 5 와 동일함.IR, NMR are the same as in Example 5.

[실시예 10]Example 10

실시예 4 에서 제조한 DMA용 매화물 8.10g 사용하여 실시예 5 와 유사한 방법으로 3시간 반응을 행하여 7-[[2-(2-아미노티아졸-4-일)-2-syn-메톡시이미노] 아세트아미도] 세팔로스포란산을 얻는다.The reaction was carried out for 3 hours in the same manner as in Example 5 using 8.10 g of the DMA solvent prepared in Example 4 to obtain 7-[[2- (2-aminothiazol-4-yl) -2-syn-methoxy. Mino] Acetamido] Obtain cephalosporanic acid.

수율 : 8.92g(98%)Yield: 8.92 g (98%)

IR, NMR은 실시예 5 와 동일함.IR, NMR are the same as in Example 5.

[실시예 11]Example 11

7-아미노[3-(1-메틸-1H-테트라졸-5-일)티오메틸]-3-세펨-4-카르복실산 3.28g을 물 35ml에 혼탁하고 탄산수소나트륨 2.0g을 가하여 실온에서 20분간 교반하여 용해시킨 후 아세토니트릴 40ml를 가하여 10℃로 냉각시킨다. 여기에 실시예 1 에서 제조한 1-[α-syn-메톡시이미노-α-(2-아미노티아졸-4-일)-아세틸]-벤조트리아졸-4-옥사이드의 DMF용매화물 4.68g을 가하여 준다. 실온에서 5시간 교반하여 주면 맑은 용액이 되면서 반응이 완결된다. 용액중의 아세토니트릴을 감압증류하여 제거하고 물층에 물 40ml를 더 가하고 2N-HCl로 pH 3.8로 조절하여 1시간 교반 후 결정을 여과하여 제거한다. 여액을 염화나트륨으로 포화시키고 2N-HCl로 pH 2.7로 조절하면 결정에 석출된다. 2시간동안 5℃에서 교반하여 주고 여과하면 목적하는 7-[[2-(2-아미노치아졸-4-일)-2-syn-메톡시이미노] 아세트아미도]-3-[(1-메틸-1H-테트라졸-5-일) 티오메틸]-3-세펨-4-카르복실산(Cefmenoxime)을 얻는다.3.28 g of 7-amino [3- (1-methyl-1H-tetrazol-5-yl) thiomethyl] -3-cepem-4-carboxylic acid was turbid in 35 ml of water, and 2.0 g of sodium hydrogencarbonate was added thereto at room temperature. After stirring for 20 minutes to dissolve, 40 ml of acetonitrile were added and cooled to 10 ° C. 4.68 g of a DMF solvate of 1- [α-syn-methoxyimino-α- (2-aminothiazol-4-yl) -acetyl] -benzotriazole-4-oxide prepared in Example 1 was added thereto. Add Stirring at room temperature for 5 hours results in a clear solution and completes the reaction. The acetonitrile in the solution was distilled off under reduced pressure, 40 ml of water was added to the water layer, and the mixture was adjusted to pH 3.8 with 2N-HCl, stirred for 1 hour, and then the crystals were filtered off. The filtrate is saturated with sodium chloride and adjusted to pH 2.7 with 2N-HCl to precipitate in the crystals. Stir at 5 ° C. for 2 hours and filter to give the desired 7-[[2- (2-aminothiazol-4-yl) -2-syn-methoxyimino] acetamido] -3-[(1- Methyl-1H-tetrazol-5-yl) thiomethyl] -3-cepem-4-carboxylic acid (Cefmenoxime).

수율 : 4.65g(91%)Yield: 4.65 g (91%)

IR (KBr, ㎝-1) : 1780(β-락탐카르보닐)IR (KBr, cm- 1 ): 1780 (β-lactamcarbonyl)

NMR(D2O/NaHCO3, δ) : 3.84(2H, d, C2-H), 4.01(3H, s, -OCH3), 4.05(3H, s, N-CH3), 5.20(1H, d, C6-H), 5.77(1H, d, C7-H), 7.01(1H, s, 치아졸-H)NMR (D 2 O / NaHCO 3 , δ): 3.84 (2H, d, C 2 -H), 4.01 (3H, s, -OCH 3 ), 4.05 (3H, s, N-CH 3 ), 5.20 (1H , d, C 6 -H), 5.77 (1H, d, C 7 -H), 7.01 (1H, s, chiazole-H)

[실시예 12]Example 12

아세토니트릴 대신에 에틸아세테이트 40ml를 사용하여 실시예 11의 방법으로 반응시켜서 목적하는 7-[[2-(2-아미노치아졸-4-일)-2-syn-메톡시이미노] 아세트아미도]-3-[(1-메틸-1H-테트라졸-5-일) 티오메틸]-3-세펨-4-카르복실산을 얻는다.40 ml of ethyl acetate instead of acetonitrile was reacted in the same manner as in Example 11 to obtain the desired 7-[[2- (2-aminothiazol-4-yl) -2-syn-methoxyimino] acetamido] Obtain 3-[(1-methyl-1H-tetrazol-5-yl) thiomethyl] -3-cefe-4-carboxylic acid.

수율 : 4.60g(90%)Yield: 4.60 g (90%)

IR, NMR은 실시예 11 과 동일함.IR, NMR are the same as in Example 11.

[실시예 13]Example 13

실시예 4 에서 제조한 DMA용매화물 4.05g을 사용하여 실시예 11과 유사한 방법으로 3시간 반응시켜서 7-[[2-(2-아미노치아졸-4-일)-2-syn-메톡시이미노] 아세트아미도]-3-[(1-메틸-1H-테트라졸-5-일)티오메틸]-3-세펨-4-카르복실산을 얻는다.4.05 g of the DMA solvate prepared in Example 4 was reacted for 3 hours in a similar manner to Example 11 to obtain 7-[[2- (2-aminothiazol-4-yl) -2-syn-methoxyimino Acetamido] -3-[(1-methyl-1H-tetrazol-5-yl) thiomethyl] -3-cefe-4-carboxylic acid.

수율 : 4.97g(94%)Yield: 4.97 g (94%)

IR, NMR 데이타는 실시예 11과 동일함.IR, NMR data are the same as in Example 11.

[실시예 14]Example 14

7-아미노-3-(2,5-디하이드로-2-메틸-6-하이드록시-5-옥소-as-트리아진-3-일) 티오메틸-3-세펨-4-카르복실산 3.71g을 물 40ml와 테트라하이드로푸란 30ml에 혼탁시키고 탄산수소나트륨 2.7g을 가하여 용해시키면 pH 8.0-8.2의 맑은 용액이 된다. 여기에 1-[α-syn-메톡시이미노-α-(2-아미노티아졸-4-일)-아세틸]-벤조트리아졸-3-옥사이드의 DMF용매화물 4.68g을 가하고 5℃에서 1시간 교반하고 온도를 25℃로 올려서 5시간 교반하면 반응이 완결된다. 감압하에서 용액중의 테트라하이드로푸란을 증발시키고 물 30ml를 더가하여 5℃로 냉각시킨다. 2N-HCl로 pH 4.2로 조절하여 30분간 교반하여 주고 생성된 불용물을 여과하여 제거한다. 여액을 염화나트륨으로 포화시키고 다시 2N-HCl로 pH 2.9-3.0으로 조절하면 침전이 생성된다. 2시간동안 일정 pH를 유지하면서 교반하여 주고 여과하여 건조하면 목적하는 7-[[2-(2-아미노치아졸-4-일)-2-syn-메톡시이미노] 아세트아미도]-3-[(2,5-디하이드로-6-하이드록시-2-메틸-5-옥소-as-트리아진-3-일) 티오메틸]-3-세펨-4-카르복실산을 얻는다.7-amino-3- (2,5-dihydro-2-methyl-6-hydroxy-5-oxo-as-triazin-3-yl) thiomethyl-3-cepem-4-carboxylic acid 3.71 g Was dissolved in 40 ml of water and 30 ml of tetrahydrofuran and dissolved by adding 2.7 g of sodium bicarbonate to obtain a clear solution of pH 8.0-8.2. To this was added 4.68 g of a DMF solvate of 1- [α-syn-methoxyimino-α- (2-aminothiazol-4-yl) -acetyl] -benzotriazole-3-oxide and 1 hour at 5 ° C. After stirring, the temperature was raised to 25 ° C. and stirred for 5 hours to complete the reaction. Tetrahydrofuran in solution was evaporated under reduced pressure, and 30 ml of water was added thereto and cooled to 5 ° C. The mixture was adjusted to pH 4.2 with 2N-HCl, stirred for 30 minutes, and the produced insolubles were removed by filtration. Saturate the filtrate with sodium chloride and adjust again to pH 2.9-3.0 with 2N-HCl to form a precipitate. Stirring at constant pH for 2 hours, filtered and dried to give the desired 7-[[2- (2-aminothiazol-4-yl) -2-syn-methoxyimino] acetamido] -3- [(2,5-Dihydro-6-hydroxy-2-methyl-5-oxo-as-triazin-3-yl) thiomethyl] -3-cepem-4-carboxylic acid is obtained.

수율 : 4.70g(85%)Yield: 4.70 g (85%)

IR (KBr, ㎝-1) : 1780IR (KBr, cm -1 ): 1780

NMR(D2O/NaHCO3, δ) : 3.20(2H, d, C2-H), 3.62(3H, s,

Figure kpo00008
N-CH3), 3.95(3H, s, -OCH3), 4.21(2H, d, -S-CH2-), 5.17(1H, d, C6-H), 5.72(1H, d, C7-H), 6.95(1H, s, 치아졸-H)NMR (D 2 O / NaHCO 3 , δ): 3.20 (2H, d, C 2 -H), 3.62 (3H, s,
Figure kpo00008
N-CH 3 ), 3.95 (3H, s, -OCH 3 ), 4.21 (2H, d, -S-CH 2- ), 5.17 (1H, d, C 6 -H), 5.72 (1H, d, C 7- H), 6.95 (1H, s, Chiazole-H)

[실시예 15]Example 15

테트라하이드로푸란 대신에 아세토니트릴 40ml를 사용하여 실시예 14의 방법으로 반응시켜서 목적하는 7-[[2-(2-아미노치아졸-4-일)-2-syn-메톡시이미노] 아세트아미도]-3-[(2,5-디하이드로-6-하이드록시-2-메틸-5-옥소-as-트리아진-3-일)-티오메틸]-3-세펨-4-카르복실산을 얻는다.The desired 7-[[2- (2-aminothiazol-4-yl) -2-syn-methoxyimino] acetamido was reacted by the method of Example 14 using 40 ml of acetonitrile instead of tetrahydrofuran. ] -3-[(2,5-dihydro-6-hydroxy-2-methyl-5-oxo-as-triazin-3-yl) -thiomethyl] -3-cef-4-carboxylic acid Get

수율 : 4.50g(81%)Yield: 4.50 g (81%)

IR, NMR은 실시예 14와 동일함.IR, NMR are the same as in Example 14.

[실시예 16]Example 16

실시예 4 에서 제조한 DMA용매화물 4.05g을 사용하고 실시예 14의 방법으로 4시간 반응을 행하여 7-[[2-(2-아미노치아졸-4-일)-2-syn-메톡시이미노] 아세트아미도]-3-[(2,5-디하이드로-6-하이드록시-2-메틸-5-옥소-as-트리아진-3-일) 티오메틸]-3-세펨-4-카복실산을 얻는다.Using 4.05 g of the DMA solvate prepared in Example 4 and reacting for 4 hours by the method of Example 14, 7-[[2- (2-aminothiazol-4-yl) -2-syn-methoxyimino Acetamido] -3-[(2,5-dihydro-6-hydroxy-2-methyl-5-oxo-as-triazin-3-yl) thiomethyl] -3-cepem-4-carboxylic acid Get

수율 : 5.27g(91%)Yield: 5.27 g (91%)

IR, NMR 데이타는 실시예 14와 동일함.IR, NMR data are the same as in Example 14.

[실시예 17]Example 17

7-아미노-3-세펨-4-카복실산 1.88g을 물 20ml와 테트라하이드로푸란 20ml에 혼탁시키고 탄산수소나트륨 2.0g을 가하여 용해시키고 5℃로 냉각시킨다. 여기에 1-[α-syn-메톡시이미노-α-(2-아미노치아졸-4-일)-아세틸]-벤조트리아졸-3-옥사이드의 DMF 용매화물 3.91g을 10분간에 걸쳐서 가한다. 계속하여 5℃에서 1시간, 25℃에서 2시간 교반하면 반응이 완결된다.1.88 g of 7-amino-3-cepem-4-carboxylic acid is turbid in 20 ml of water and 20 ml of tetrahydrofuran, 2.0 g of sodium bicarbonate is added to dissolve, and cooled to 5 ° C. To this was added 3.91 g of a DMF solvate of 1- [α-syn-methoxyimino-α- (2-aminothiazol-4-yl) -acetyl] -benzotriazole-3-oxide over 10 minutes. . Then, the reaction is completed by stirring at 5 ° C for 1 hour and at 25 ° C for 2 hours.

감압하에서 용액중의 테트라하이드로푸란을 증발시키고 물 15ml를 더 가하여 5℃로 냉각시킨다. 2N-HCl로 pH 4.2로 조절하여 30분 교반하여 주고 생성된 불용물을 여과하여 제거한다. 여액을 염화나트륨으로 포화시키고 다시 2N-HCl로 pH 2.8로 조절하면 침전이 생성된다. 2시간동안 일정 pH를 유지하면서 빙냉하에 교반하여 준 후 여과한다. 포화소금물, 냉각수로 세척하여 건조하면 목적하는 7-[[2-(2-아미노치아졸-4-일)-2-syn-메톡시이미노] 아세트아미도]-3-세펨-4-카복실산을 얻는다.Tetrahydrofuran in solution is evaporated under reduced pressure, and 15 ml of water is further added and cooled to 5 ° C. The mixture was adjusted to pH 4.2 with 2N-HCl, stirred for 30 minutes, and the produced insolubles were removed by filtration. Saturate the filtrate with sodium chloride and adjust again to pH 2.8 with 2N-HCl to form a precipitate. After stirring for 2 hours while maintaining a constant pH under ice cooling, and filtered. After washing with saturated brine and cooling water and drying, the desired 7-[[2- (2-aminothiazol-4-yl) -2-syn-methoxyimino] acetamido] -3-cepem-4-carboxylic acid Get

수율 : 3.48g(91%)Yield: 3.48 g (91%)

IR(KBr, cm-1) : 1780, 1695, 1655IR (KBr, cm -1 ): 1780, 1695, 1655

NMR(DMSO-d6, δ) : 3.60(2H, broad, C2-H), 3.84(3H, s, -OCH3), 5.12(1H, d, C6-H), 5.84(1H, dd, C7-H), 6.52(1H, s, 3-H), 6.76(1H, s, 치아졸-H), 7.26(2H, broad, -NH2),9.65(1H, d, -NH-CO-)NMR (DMSO-d 6 , δ): 3.60 (2H, broad, C 2 -H), 3.84 (3H, s, -OCH 3 ), 5.12 (1H, d, C 6 -H), 5.84 (1H, dd , C 7 -H), 6.52 (1H, s, 3-H), 6.76 (1H, s, chizol-H), 7.26 (2H, broad, -NH 2 ), 9.65 (1H, d, -NH- CO-)

[실시예 18]Example 18

테트라하이드로푸란 대신에 아세톤 20ml를 사용하여 실시예 17의 방법으로 반응시켜서 목적하는 7-[[2-(2-아미노치아졸-4-일)-2-syn-메톡시이미노] 아세트아미도]-3-세펨-4-카복실산을 얻는다.20 ml of acetone instead of tetrahydrofuran was reacted by the method of Example 17 to obtain the desired 7-[[2- (2-aminothiazol-4-yl) -2-syn-methoxyimino] acetamido] Obtain -3-cefe-4-carboxylic acid.

수율 : 3.40g(90%)Yield: 3.40 g (90%)

IR, NMR 은 실시예 17과 동일함.IR, NMR are the same as in Example 17.

[실시예 19]Example 19

실시예 4 에서 제조한 DMA 용매화물 4.05g을 사용하여 실시예 17과 유사한 방법으로 3시간 반응시켜서 7-[[2-아미노치아졸-4-일)-2-syn-메톡시이미노] 아세트아미도]-3-세펨-4-카복실산을 얻는다.Using 4.05 g of the DMA solvate prepared in Example 4, the reaction was carried out for 3 hours in the same manner as in Example 17 to obtain 7-[[2-aminothiazol-4-yl) -2-syn-methoxyimino] acetami Fig.]-3-cepem-4-carboxylic acid is obtained.

수율 : 5.27g(94%)Yield: 5.27 g (94%)

IR 및 NMR 데이타는 실시예 17에서와 동일함.IR and NMR data are the same as in Example 17.

Claims (1)

(정정) 구조식(Ⅳ)의 디알킬 (또는 디알릴) 클로로치오포스페이트와 구조식(Ⅴ)의 1-하이드록시벤조 트리아졸을 반응시켜 얻어진 구조식(Ⅵ) 화합물과 구조식(Ⅱ)의 유기산을 반응시켜 얻어진 구조식(Ⅷ)의 반응성 아마이드의 용매화물을 구조식(Ⅲ) 화합물과 아실화 반응을 시켜서 구조식(Ⅰ) 화합물을 제조하는 방법.(Correction) By reacting the dialkyl (or diallyl) chlorothio phosphate of formula (IV) with 1-hydroxybenzotriazole of formula (V) and the organic acid of formula (II) A method of producing the compound of formula (I) by subjecting the solvate of the reactive amide of formula (III) to an acylation reaction with the compound of formula (III).
Figure kpo00009
Figure kpo00009
상기식에서,In the above formula, R1은 수소 또는 알카리금속 또는 알카리토류금속 :R 1 is hydrogen or alkali metal or alkaline earth metal: R2는 수소, 아세톡시메틸, (1-메틸-1H-테트라졸-5-일) 티오메틸 또는 (2,5-디하이드로-6-하이드록시-2-메틸-5-옥소-as-트리아진-3-일) 티오메틸을 의미한다.R 2 is hydrogen, acetoxymethyl, (1-methyl-1H-tetrazol-5-yl) thiomethyl or (2,5-dihydro-6-hydroxy-2-methyl-5-oxo-as-tri Azin-3-yl) thiomethyl. R4는 에틸 또는 페닐을 의미한다R 4 means ethyl or phenyl
KR1019850001654A 1984-11-03 1985-03-14 Process for preparing cephem derivatives KR870001984B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1019850001654A KR870001984B1 (en) 1985-03-14 1985-03-14 Process for preparing cephem derivatives
IT67781/85A IT1189604B (en) 1984-11-03 1985-09-16 PREPARATION PROCEDURE FOR CEFEM DERIVATIVES
JP22109685A JPS61186391A (en) 1984-11-03 1985-10-03 Manufacture of cephem derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019850001654A KR870001984B1 (en) 1985-03-14 1985-03-14 Process for preparing cephem derivatives

Publications (2)

Publication Number Publication Date
KR860007267A KR860007267A (en) 1986-10-10
KR870001984B1 true KR870001984B1 (en) 1987-10-24

Family

ID=19240113

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850001654A KR870001984B1 (en) 1984-11-03 1985-03-14 Process for preparing cephem derivatives

Country Status (1)

Country Link
KR (1) KR870001984B1 (en)

Also Published As

Publication number Publication date
KR860007267A (en) 1986-10-10

Similar Documents

Publication Publication Date Title
US4433141A (en) Intermediate for use in the preparation of cephalosporin antibiotics
KR20030078882A (en) Novel thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds
KR870001332B1 (en) Process for preparing cephem derivatives
EP0628561B1 (en) Process for preparing cephalosporin compounds from reactive organic acid derivatives
KR870001984B1 (en) Process for preparing cephem derivatives
CA1280409C (en) Method of producing cephem compounds
KR870001333B1 (en) Process for preparing cephem derivatives
US5317099A (en) Process for the preparation of cephem derivatives
EP0019067B1 (en) 5,10-dioxo-5,10-dihydrodiimidazo(1,5-a,1',5'-d)pyrazine-1,6-dicarboxylic acid and a process for producing imidazoledicarboxylic acid amido-derivatives
KR850001206B1 (en) Process for preparing cephem derivatives
US5856502A (en) Method for manufacture of cephalosporin and intermediates thereof
SU784780A3 (en) Method of preparing d-isomers of penicillin derivatives or their pharmaceutically employed salts
JPH0546354B2 (en)
KR0129567B1 (en) The process for preparation of cephalosporins
US5162522A (en) Method for producing cephem compounds
US5831085A (en) Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof
US4304909A (en) Process for producing 7-(D(-)-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-α-(4-hydroxyphenyl)acetamido)-3-(5-(1-methyl-1,2,3,4-tetrazolyl)thiomethyl)-.DELTA.3 -cephem-4-carboxylic acid and a pharmaceutically acceptable salt thereof
KR830002896B1 (en) Process for preparing cephalosporin derivatives
KR950008320B1 (en) 7 beta-(substituted) amino-3-substituted cephalosporanic acids and esters
KR970005893B1 (en) Process for preparing cephalosporin compounds
HU192983B (en) Process for production of cefem compounds
KR810000635B1 (en) Process for preparing cephalosporin compounds
EP0002586B1 (en) Method for removing a halogenoacetyl protective group from a halogenoacetyl amino compound
KR100213443B1 (en) Novel process for preparing cephem derivatives
KR100213442B1 (en) Novel process for preparing cephem derivatives

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
G160 Decision to publish patent application
O035 Opposition [patent]: request for opposition

Free format text: OPPOSITION NUMBER: 001987000233001987000540; OPPOSITION DATE: 26230127